The protospacer adjacent motif, or PAM, provides a required DNA landmark next to the sequence recognized by the guide RNA. Cas9 uses this neighboring motif to identify a suitable target before making a double-strand break. Consequently, a complementary sequence alone may not be sufficient for editing, because target selection also depends on the presence of an appropriate adjacent PAM.
Guide RNA directs the CRISPR-associated nuclease by carrying a sequence complementary to the intended DNA target. This pairing positions the nuclease at a selected genomic location, where it can cut the DNA. The relationship between guide sequence and target therefore determines editing placement, making guide design central to studying a particular gene or genomic region.
The cell repairs the double-strand break generated by Cas9, and that repair process produces the editing outcome. Depending on the intended experiment, repair can disrupt a gene or support modification of a DNA sequence. Researchers therefore interpret CRISPR results not only from the cutting event itself, but also from how cellular repair changes the targeted genetic information.
A typical workflow selects a DNA region of interest, designs a guide RNA with a complementary sequence, and identifies a compatible adjacent PAM. The guide RNA then directs a CRISPR-associated nuclease, such as Cas9, to that site. After the targeted break occurs, researchers examine the cell's repair outcome to determine whether gene disruption or sequence modification was achieved.
Researchers apply CRISPR technology when they need to connect a gene with a biological role by altering its sequence and examining the resulting consequences. Gene disruption can help reveal what changes when a gene no longer functions normally, while targeted sequence modification can test specific genetic changes. These experiments support functional genomics and broader studies in cell biology.
Its applications extend from functional genomics and disease modeling to crop improvement and investigation of potential therapies. In disease models, targeted genetic changes can help examine biological mechanisms associated with disease. In agriculture and biotechnology, the same adaptable approach supports research on useful traits or engineered biological outcomes, while its precision helps focus experiments on selected DNA regions.